Aalberts N.V.
Aalberts N.V. (AALBF) Financial Performance & Income Statement Overview
Review Aalberts N.V. (AALBF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Aalberts N.V. (AALBF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Aalberts N.V. AALBF financial performance.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $1.53B | $1.62B | $1.61B | $803.40M |
| Cost of Revenue | $1.15B | $586.20M | $1.15B | $301.30M |
| Gross Profit | $380.60M | $1.03B | $452.10M | $502.10M |
| Gross Profit Ratio | $0.25 | $0.64 | $0.28 | $0.62 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $294.10M | $472.20M | $264.90M | $241.35M |
| Operating Expenses | $267.60M | $818.90M | $224.20M | $391.35M |
| Total Costs & Expenses | -$1.42B | $1.41B | $1.38B | $692.65M |
| Interest Income | $0.00 | $0.00 | $0.00 | $6.40M |
| Interest Expense | $17.00M | $13.80M | $19.20M | $0.00 |
| Depreciation & Amortization | $115.00M | $103.50M | $101.30M | $38.90M |
| EBITDA | $193.60M | $317.30M | $135.05M | $135.05M |
| EBITDA Ratio | $0.13 | $0.20 | $0.20 | $0.17 |
| Operating Income | $113.00M | $213.80M | $227.90M | $96.15M |
| Operating Income Ratio | $0.07 | $0.13 | $0.14 | $0.12 |
| Other Income/Expenses (Net) | -$51.40M | -$13.80M | -$123.55M | -$9.60M |
| Income Before Tax | $61.60M | $200.00M | $208.70M | $104.35M |
| Income Before Tax Ratio | $0.04 | $0.12 | $0.13 | $0.13 |
| Income Tax Expense | $24.30M | $49.90M | $50.70M | $25.35M |
| Net Income | $29.90M | $149.20M | $155.80M | $77.90M |
| Net Income Ratio | $0.02 | $0.09 | $0.10 | $0.10 |
| EPS | $0.27 | $1.35 | $1.41 | $0.70 |
| Diluted EPS | $0.27 | $1.35 | $1.41 | $0.70 |
| Weighted Avg Shares Outstanding | $110.58M | $110.52M | $110.58M | $110.82M |
| Weighted Avg Shares Outstanding (Diluted) | $110.58M | $110.52M | $110.58M | $110.82M |
The company's financials show resilient growth, with revenue advancing from $803.40M in Q3 2023 to $1.53B in Q4 2024. Gross profit remained healthy with margins at 25% in Q4 2024 compared to 62% in Q3 2023. Operating income hit $113.00M last quarter, sustaining a consistent 7% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $193.60M. Net income dropped to $29.90M, while earnings per share reached $0.27. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan